Agathe Vermorel
Overview
Explore the profile of Agathe Vermorel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study
Bakis H, Trimouille A, Vermorel A, Goizet C, Belaroussi Y, Schutz S, et al.
Clin Kidney J
. 2023 Feb;
16(1):100-110.
PMID: 36726431
Background: Mitochondrial functions are controlled by genes of both mitochondrial and nuclear DNA. Pathogenic variants affecting any of these are responsible for primary mitochondrial disorders (MIDs), which can be diagnosed...
2.
Chauveau B, Merville P, Soulabaille B, Taton B, Kaminski H, Visentin J, et al.
Kidney360
. 2022 Dec;
3(11):1924-1933.
PMID: 36514413
Background: Fibrosis progression is a major prognosis factor in kidney transplantation. Its assessment requires an allograft biopsy, which remains an invasive procedure at risk of complications. Methods: We assessed renal...
3.
Chauveau B, Garric A, Di Tommaso S, Raymond A, Visentin J, Vermorel A, et al.
Sci Rep
. 2022 Nov;
12(1):19094.
PMID: 36352007
Antibody-mediated rejection (ABMR) is the leading cause of allograft failure in kidney transplantation. Defined by the Banff classification, its gold standard diagnosis remains a challenge, with limited inter-observer reproducibility of...
4.
Vial G, Barthod L, Schneider S, Mercie P, Duffau P, Vermorel A, et al.
Open Forum Infect Dis
. 2022 Aug;
9(8):ofac351.
PMID: 35991591
Chronic active Epstein-Barr virus (CAEBV) infection is usually a fatal disease associated with clonal proliferation of EBV-infected T or NK cells. We present the case of a 33-year-old Peruvian patient...
5.
Kaminski H, Gigan M, Vermorel A, Charrier M, Guirle L, Jambon F, et al.
Kidney Int
. 2022 Jul;
102(4):936-938.
PMID: 35870641
No abstract available.
6.
Chauveau B, Raymond A, Di Tommaso S, Visentin J, Vermorel A, Dugot-Senant N, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327371
Antibody-mediated rejection (ABMR) is the leading cause of allograft failure in kidney transplantation. Its histological hallmark is represented by lesions of glomerulitis i.e., inflammatory cells within glomeruli. Current therapies for...
7.
Scherlinger M, Guillotin V, Douchet I, Vacher P, Boizard-Moracchini A, Guegan J, et al.
Sci Transl Med
. 2021 Jul;
13(600).
PMID: 34193612
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of tolerance toward self-nucleic acids, autoantibody production, interferon expression and signaling, and a defect in the regulatory...
8.
Tinel C, Vermorel A, Picciotto D, Morin L, Devresse A, Sauvaget V, et al.
Front Immunol
. 2020 Dec;
11:604353.
PMID: 33362789
BK virus (BKV) replication increases urinary chemokine C-X-C motif ligand 10 (uCXCL10) levels in kidney transplant recipients (KTRs). Here, we investigated uCXCL10 levels across different stages of BKV replication as...
9.
Tinel C, Devresse A, Vermorel A, Sauvaget V, Marx D, Avettand-Fenoel V, et al.
Am J Transplant
. 2020 Apr;
20(12):3462-3476.
PMID: 32342614
The urinary chemokines CXCL9 and CXCL10 are promising noninvasive diagnostic markers of acute rejection (AR) in kidney recipients, but their levels might be confounded by urinary tract infection (UTI) and...
10.
Calvani J, Terada M, Lesaffre C, Eloudzeri M, Lamarthee B, Burger C, et al.
Am J Transplant
. 2019 Nov;
20(4):942-953.
PMID: 31715060
The exact composition of leukocyte infiltration during kidney allograft rejection is difficult to comprehend and visualize on the same biopsy slide. Using an innovative technology of multiplex immunofluorescence (mIF), we...